• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, April 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New and better marker for assessing patients after cardiac arrest

Bioengineer by Bioengineer
October 30, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Last year, researchers Tobias Cronberg and Niklas Mattsson at Lund University in Sweden published a study showing serum tau levels to be a new and promising marker for identifying patients with severe brain damage after cardiac arrest. Together with Marion Moseby Knappe, they have now discovered that the protein Neurofilament light (NFL) in serum constitutes an even better marker to identify the degree of brain damage after cardiac arrest. This information could form the basis for decisions on continuing life-support treatment.

The study is an international collaboration including research colleagues from the Sahlgrenska Neurochemistry laboratory in Mölndal. Samples from more than 700 patients that were part of the largest ever study on cardiac arrest, TTM, were included. The results are now published in the scientific journal JAMA Neurology.

"We investigated serum Neurofilament light (NFL) with the same new hypersensitive investigation technology as Tobias Cronberg and Niklas Mattsson used for tau. In this new study, we found that serum NFL was an excellent marker for identifying the degree of brain damage after cardiac arrest. We also compared NFL with three other biomarkers, including tau and other standard methods used to predict outcome in patients after cardiac arrest", says one of the lead authors of the study, Marion Moseby Knappe, who is a researcher at the Centre for Cardiac Arrest at Lund University and a neurologist at Skåne University Hospital in Lund, Sweden.

Patients who have been resuscitated after cardiac arrest are often unconscious for the first few days due to brain damage, and around half of them die. Using neurophysiological measurements, radiological and neurological examinations, physicians obtain a picture of the extent of the patient's brain damage. This information then forms the basis for decisions on continuing or terminating life-supporting treatment.

"The new method consists of a simple blood test and can make these assessments more secure", says Marion Moseby Knappe.

"However, it is important to emphasise that the method is new and has so far only been used in a research context. If these results can be confirmed in further studies, in future, it might be possible to assess prognosis for recovery after cardiac arrest even earlier than we do today. Thereby, we could also spare patients and their loved ones unnecessary suffering and make healthcare more efficient", says Tobias Cronberg, professor and consultant neurologist at the Centre for Cardiac Arrest at Lund University and Skåne University Hospital.

In this study, the level of NFL in the blood was a better marker for brain damage than any of the available methods currently in clinical use, according to the researchers behind the study.

The researchers found that, twenty-four hours after cardiac arrest, the blood levels of NFL already corresponded very well with the patients' neurological function levels six months later. NFL also appear to help in identifying patients with a low degree of brain damage, which could be significant for patients who have a chance of waking up.

###

Media Contact

Marion Moseby Knappe
[email protected]
46-761-918-028
@lunduniversity

http://www.lu.se

http://dx.doi.org/10.1001/jamaneurol.2018.3223

Share12Tweet7Share2ShareShareShare1

Related Posts

Comparing Amoxicillin-Clavulanate and Amoxicillin for Treating Acute Sinusitis in Adults

April 18, 2026

Blocking RIPK1/RIPK3-MLKL Reduces Preterm Birth

April 18, 2026

Barriers to Immunity Research in Elder Care Populations

April 18, 2026

Unraveling Kidney Cancer Genetics Across Ancestral Groups

April 18, 2026
Please login to join discussion

POPULAR NEWS

  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    62 shares
    Share 25 Tweet 16
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    100 shares
    Share 40 Tweet 25
  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    46 shares
    Share 18 Tweet 12

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Comparing Amoxicillin-Clavulanate and Amoxicillin for Treating Acute Sinusitis in Adults

HMO Profile Shifts: Biochemical to Clinical Insights

Blocking RIPK1/RIPK3-MLKL Reduces Preterm Birth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 79 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.